HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

TAX2 peptide

anticancer synthetic

Also Known As:

CEVSQLLKGDAC

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - TAX2 peptide: 5
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - TAX2 peptide: 5

Experts

1.	Dedieu, Stéphane: 5 articles (04/2019 - 07/2015)
2.	Jeanne, Albin: 5 articles (04/2019 - 07/2015)
3.	Martiny, Laurent: 5 articles (04/2019 - 07/2015)
4.	Boulagnon-Rombi, Camille: 3 articles (01/2017 - 07/2015)
5.	Devy, Jérôme: 2 articles (10/2016 - 07/2015)
6.	Diebold, Marie-Danièle: 2 articles (10/2016 - 07/2015)
7.	Schneider, Christophe: 2 articles (10/2016 - 07/2015)
8.	Lamensdorf, Itschak: 1 article (04/2019)
9.	Martin, Celine: 1 article (04/2019)
10.	Rattenbach, Revital: 1 article (04/2019)

Related Diseases

1.	Neoplasms (Cancer) 07/20/2015 - "Identification of TAX2 peptide as a new unpredicted anti-cancer agent." 04/01/2019 - "Correction: Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma." 01/01/2017 - "In the B16 melanoma allograft model, endogenous lumican inhibits tumor growth and modulates response to TAX2 peptide. " 01/01/2017 - "Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma."
2.	Neuroblastoma 01/01/2017 - "Altogether, our results present TAX2 peptide specifically targeting TSP-1:CD47 interaction as a new putative therapeutic approach for treating neuroblastoma, whether utilized alone or in combination with existing chemotherapy drugs." 04/01/2019 - "Correction: Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma." 01/01/2017 - "Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma."
3.	Experimental Melanoma 01/01/2017 - "In the B16 melanoma allograft model, endogenous lumican inhibits tumor growth and modulates response to TAX2 peptide. "
4.	Melanoma (Melanoma, Malignant) 10/01/2016 - "Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide."

Related Drugs and Biologics

1.	Thrombospondins
2.	Therapeutic Uses
3.	Thrombospondin 1
4.	Lumican

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)